SCHEMBL11940463

SCHEMBL11940463

CCC(=O)N[C@@H](CCSC)C(=O)OC

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.56
ALDH1A1 P00352 1/20 0.54
TSHR P16473 1/20 0.53
TAS1R3 Q7RTX0 2/20 0.51
TAS1R1 Q7RTX1 2/20 0.51
USP2 O75604 1/20 0.51
GAA P10253 1/20 0.50
HTT P42858 1/20 0.49
HPGD P15428 1/20 0.48
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 1/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
CASP1 P29466 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25724298 0.86 CYP2C9 (0.62) CYP2C9L3MBTL1ALDH1A1TSHRTAS1R3
SCHEMBL28046500 0.85 CYP2C9 (0.57) CYP2C9L3MBTL1ALDH1A1TSHRTAS1R3
SCHEMBL28046501 0.85 CYP2C9 (0.57) CYP2C9L3MBTL1ALDH1A1TSHRTAS1R3
SCHEMBL7749748 0.85 CYP2C9 (0.57) CYP2C9L3MBTL1ALDH1A1TSHRTAS1R3
SCHEMBL7749751 0.85 CYP2C9 (0.57) CYP2C9L3MBTL1ALDH1A1TSHRTAS1R3
SCHEMBL14439338 0.84 CTSS (0.48) CYP2C9L3MBTL1ALDH1A1TSHRTAS1R3
SCHEMBL13198957 0.84 ALDH1A1 (0.57) CYP2C9L3MBTL1ALDH1A1TSHRTAS1R3
Hydrochloric Acid SCHEMBL8368672 0.83 CYP2C9 (0.56) CYP2C9L3MBTL1ALDH1A1TSHRTAS1R3
Hydrochloric Acid SCHEMBL8368674 0.83 CYP2C9 (0.56) CYP2C9L3MBTL1ALDH1A1TSHRTAS1R3
SCHEMBL111170 0.82 ALDH1A1 (0.56) CYP2C9L3MBTL1ALDH1A1TSHRTAS1R3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9243028-B2 Facile amide formation via S-nitroso thioacid intermediates WASHINGTON STATE UNIVERSITY (US) 2016-01-26 US disclosed
US-20120190820-A1 FACILE AMIDE FORMATION VIA S-NITROSO THIOACID INTERMEDIATES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190820-A1 FACILE AMIDE FORMATION VIA S-NITROSO THIOACID INTERMEDIATES NAAA, TST, ASNS CYP2C9 1468/4885L3MBTL1 2874/4885ALDH1A1 3056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.